{"id":7221,"date":"2017-08-23T13:43:37","date_gmt":"2017-08-23T17:43:37","guid":{"rendered":"http:\/\/localhost:10028\/uncategorized\/rheumatoid-arthritis-actemra-lawsuits\/"},"modified":"2017-08-23T13:43:37","modified_gmt":"2017-08-23T17:43:37","slug":"romatoid-artrit-actemra-davalar","status":"publish","type":"post","link":"https:\/\/napolilaw.lemonadestand.org\/tr\/article\/romatoid-artrit-actemra-davalar\/","title":{"rendered":"Romatoid Artrit: Actemra Davalar\u0131"},"content":{"rendered":"<p>Actemra, romatoid artrit tedavisi i\u00e7in hastalara verilen re\u00e7eteli bir ila\u00e7t\u0131r. \u0130lac\u0131n hastalar\u0131n a\u011fr\u0131lar\u0131n\u0131 ve hastal\u0131\u011f\u0131n neden oldu\u011fu s\u0131n\u0131rlamalar\u0131 a\u015fmas\u0131na yard\u0131mc\u0131 olmas\u0131 beklenirken, <a href=\"\/tr\/uygulama-alanlari-2\/ilac-davasi\/new-york-actemra-avukatlari\/\">Actemra (etkin madde tocilizumab)<\/a> ciddi yan etkilerle ili\u015fkilendirildi ve etkilenen bir\u00e7ok hasta, Actemra&#039;n\u0131n \u00fcreticisi Roche&#039;a dava a\u00e7arak harekete ge\u00e7ti. \u0130\u015fte bilmeniz gerekenler:<\/p>\n<p>&nbsp;<\/p>\n<h2>Actemra&#039;n\u0131n Tehlikeli Yan Etkileri<\/h2>\n<p>yay\u0131nlanan bir makaleye g\u00f6re <a href=\"https:\/\/www.statnews.com\/2017\/06\/05\/actemra-rheumatoid-arthritis-fda\/\" target=\"_blank\" rel=\"noopener\">STAT Haberleri<\/a> 2017 y\u0131l\u0131n\u0131n Haziran ay\u0131nda, Actemra&#039;n\u0131n kullan\u0131m\u0131 \u015fu sonu\u00e7lara yol a\u00e7t\u0131: <strong>y\u00fczlerce hasta \u00f6l\u00fcm\u00fc<\/strong> Amerika Birle\u015fik Devletleri genelinde. Asl\u0131nda, ilac\u0131n eyaletlerde onaylanmas\u0131ndan ve piyasaya sunulmas\u0131ndan bu yana ge\u00e7en yedi y\u0131lda, romatoid artrit ila\u00e7lar\u0131ndan en az 500.000 yan etki raporu al\u0131nd\u0131 ve kan\u0131tlar, Actemra alman\u0131n a\u015fa\u011f\u0131daki riskleri \u00f6nemli \u00f6l\u00e7\u00fcde art\u0131rd\u0131\u011f\u0131n\u0131 g\u00f6steriyor:<\/p>\n<ul>\n<li>Kalp krizi;<\/li>\n<li>Fel\u00e7;<\/li>\n<li>Kalp yetmezli\u011fi;<\/li>\n<li>Akci\u011fer hastal\u0131\u011f\u0131;<\/li>\n<li>pankreatit; Ve<\/li>\n<li>Di\u011fer t\u0131bbi durumlar.<\/li>\n<\/ul>\n<p>Bu risklere ek olarak, <a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/125276lbl.pdf\" target=\"_blank\" rel=\"noopener\">FDA&#039;n\u0131n Actemra uyar\u0131s\u0131<\/a> etiket ayr\u0131ca \u015fu metni de i\u00e7erir - &quot;Uyar\u0131: Ciddi Enfeksiyon Riski.&quot; Uyar\u0131, Actemra alman\u0131n bakteriyel enfeksiyonlar, istilac\u0131 mantar veya viral enfeksiyonlar ve t\u00fcberk\u00fcloz dahil olmak \u00fczere ciddi enfeksiyon veya \u00f6l\u00fcme yol a\u00e7abilece\u011fini a\u00e7\u0131klamaya devam ediyor.<\/p>\n<p>&nbsp;<\/p>\n<h3>Ciddi Zarar Uyar\u0131s\u0131 Yok<\/h3>\n<p>FDA enfeksiyonlara kar\u015f\u0131 uyar\u0131da bulunabilirken, ne Roche ne de FDA, di\u011fer tehlikeli durumlar\u0131n yan\u0131 s\u0131ra ila\u00e7la ili\u015fkili olas\u0131 kalp riskleri ve inme riskleri konusunda doktorlar\u0131 ve hastalar\u0131n\u0131 uyaran Actemra&#039;ya bir uyar\u0131 etiketi eklemek i\u00e7in harekete ge\u00e7medi. Yine de Actemra, \u00fcretici Genentech ve ana \u015firketi Roche i\u00e7in $1,5 milyardan fazla tahmini gelir elde ederken, yar\u0131m milyondan fazla kez re\u00e7ete edildi.<\/p>\n<p>&nbsp;<\/p>\n<h3>Do\u011fal Alternatifler<\/h3>\n<p>Bir\u00e7ok hasta, tehlikeli yan etkileri olmayan artrit ila\u00e7lar\u0131 i\u00e7in do\u011fal alternatifler ke\u015ffetmeye ba\u015flad\u0131. En pop\u00fcler alternatif homeopatik ila\u00e7lardan biri, <a href=\"https:\/\/www.cognitune.com\/turmeric-curcumin-benefits\/\" class=\"follow\" target=\"_blank\" rel=\"noopener\">zerde\u00e7al takviyesi<\/a>. K\u00f6ride yayg\u0131n olarak bulunan zerde\u00e7al, Actemra&#039;n\u0131n tehlikeleri olmadan, Actemra&#039;ya benzer \u015fekilde romatoid artritle sava\u015fmaya yard\u0131mc\u0131 oldu\u011fu g\u00f6sterilen Curcumin adl\u0131 kimyasal bir bile\u015fik i\u00e7erir.<\/p>\n<p>&nbsp;<\/p>\n<h3>Hastalar Verdikleri Zarar\u0131n Tazminini \u0130stiyor<\/h3>\n<p>Hastalar\u0131n \u00f6nemli \u00f6l\u00e7\u00fcde zarar g\u00f6rmesine ve\/veya \u00f6l\u00fcm\u00fcne neden olacak kadar tehlikeli olan re\u00e7eteli bir ilac\u0131n \u00fcretimi veya onaylanmas\u0131 i\u00e7in hi\u00e7bir mazeret yoktur. Etkilenen hastalar\u0131n bir\u00e7o\u011fu ve Actemra&#039;ya ba\u011fl\u0131 yan etkilerden \u00f6len hastalar\u0131n hayatta kalan aile \u00fcyeleri dava a\u00e7t\u0131. Bu davalar, uyar\u0131 yap\u0131lmamas\u0131, tehlikeli bir ilac\u0131n \u00fcretilmesi ve ay\u0131pl\u0131 \u00fcr\u00fcn\u00fcn pazarlanmas\u0131 iddialar\u0131na dayanmaktad\u0131r.<\/p>\n<p>&nbsp;<\/p>\n<h3>Sizi desteklemek i\u00e7in buraday\u0131z<\/h3>\n<p>If you or a loved one has taken Actemra and suffered any of the life-threatening side effects listed above, you may have a personal injury suit. To learn more and work with a legal professional who will put you first, contact the offices of Napoli Shkolnik  for a <a href=\"\/tr\/bize-ulasin\/\">\u00fccretsiz dan\u0131\u015fmanl\u0131k<\/a> Bug\u00fcn. Davan\u0131z\u0131 kazanmad\u0131\u011f\u0131m\u0131z s\u00fcrece herhangi bir \u00fccret al\u0131nmaz.<\/p>","protected":false},"excerpt":{"rendered":"<p>Actemra, romatoid artrit tedavisi i\u00e7in hastalara verilen re\u00e7eteli bir ila\u00e7t\u0131r. \u0130lac\u0131n, hastalar\u0131n a\u011fr\u0131lar\u0131n\u0131n \u00fcstesinden gelmelerine yard\u0131mc\u0131 olmas\u0131 beklenirken ve\u2026<\/p>","protected":false},"author":3,"featured_media":7222,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[776],"tags":[877],"class_list":["post-7221","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceutical-litigation","tag-drug-side-effects"],"acf":[],"page_builder_type":"gutenberg","gutenberg_data":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts\/7221","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/comments?post=7221"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts\/7221\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media\/7222"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media?parent=7221"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/categories?post=7221"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/tags?post=7221"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}